EURACTIV – Adjust prices to save drugs, generics industry tells EU

6 February 2023

The generics industry is urging EU and national governments to […]

POLITICO – Everything you wanted to know about the EU’s pharma reform (but were too afraid to ask)

17 January 2023

Can the European Union bring eye-wateringly expensive medicines to the […]

PHARMA BOARDROOM – Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry

19 October 2022

Victor Mendonça, chair of the Generic Market Access Committee at […]

MANUFACTURING CHEMIST – EU supply chain regulation: what will it mean for companies attending CPHI?

17 October 2022

Ahead of her session on “Manufacturing Excellence” at CPHI Frankfurt […]

PHARMACEUTICAL TECHNOLOGY – Inflation drives pharma manufacturing to focus on sustainability

11 October 2022

Inflation is at an all-time high, opening an opportunity for […]

REUTERS – Europe’s generic drugmakers say they may cut output due to energy bills

28 September 2022

The generic drug industry lobby group Medicines for Europe on […]

CORREO FARMACEUTICO – Elisabeth Stampa Stampa, Presidenta de Medicines for Europe y Consejera Delegata de Medichem

31 March 2022

REGULATORY FOCUS – New reports address generics pricing, innovation in the EU

2 December 2021

Open

Open letter: Urgent call to amend the Temporary State Aid Framework to achieve the Recovery and Resiliency Facility objectives

17 November 2021

Margaritis Schinas and Adrian Van Den Hoven visited ELPEN

15 November 2021